These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 22710943)
1. Building a Spanish-Latin American network on drug induced liver injury: much to get from a joint collaborative initiative. Bessone F; Hernandez N; Dávalos M; Paraná R; Schinoni MI; Lizarzabal M; Kershenobich D; Loaeza A; Arrese M; Chirino RA; Méndez-Sánchez N; Fay F; Bruguera M; Stephens C; Lucena MI; Andrade RJ Ann Hepatol; 2012; 11(4):544-9. PubMed ID: 22710943 [No Abstract] [Full Text] [Related]
2. The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative. Bessone F; Hernandez N; Lucena MI; Andrade RJ; Int J Mol Sci; 2016 Feb; 17(3):313. PubMed ID: 26938524 [TBL] [Abstract][Full Text] [Related]
3. High Prevalence of Ibuprofen Drug-Induced Liver Injury in Spanish and Latin-American Registries. Zoubek ME; González-Jimenez A; Medina-Cáliz I; Robles-Díaz M; Hernandez N; Romero-Gómez M; Bessone F; Hallal H; Cubero FJ; Lucena MI; Stephens C; Andrade RJ Clin Gastroenterol Hepatol; 2018 Feb; 16(2):292-294. PubMed ID: 28782674 [No Abstract] [Full Text] [Related]
4. [Hepatotoxicity, a global problem with local features: toward the creation of a Pan-American Hepatotoxicity Network]. Lucena MI; Cohen H; Hernández N; Bessone F; Dacoll C; Stephens C; Borraz Y; Ulzurrun E; Bruguera M; Andrade RJ Gastroenterol Hepatol; 2011 May; 34(5):361-8. PubMed ID: 21419525 [TBL] [Abstract][Full Text] [Related]
6. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method. Teschke R Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694 [TBL] [Abstract][Full Text] [Related]
7. Drug-Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Using Different MedDRA Terms. Gahr M; Zeiss R; Lang D; Connemann BJ; Hiemke C; Schönfeldt-Lecuona C J Clin Pharmacol; 2016 Jun; 56(6):769-78. PubMed ID: 26470856 [TBL] [Abstract][Full Text] [Related]
8. Recent global endeavors in the detection and prevention of drug-induced liver injury. Huang YS J Formos Med Assoc; 2012 May; 111(5):237-8. PubMed ID: 22656392 [No Abstract] [Full Text] [Related]
9. FDA's sentinel network: a monumental task. Young D Am J Health Syst Pharm; 2007 Apr; 64(8):800-1. PubMed ID: 17420189 [No Abstract] [Full Text] [Related]
10. The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia. ; Andersen M; Bergman U; Choi NK; Gerhard T; Huang C; Jalbert J; Kimura M; Kimura T; Kubota K; Lai EC; Ooba N; Park BJ; Pratt N; Roughead EE; Sato T; Setoguchi S; Shin JY; Sundström A; Yang YH Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):700-4. PubMed ID: 23653370 [No Abstract] [Full Text] [Related]
11. [Official systems of pharmacovigilance in France and in Spain. Comparison of spontaneous reporting in two regional centers: Pays Basque and Bordeaux]. Aguirre C; Haramburu F Therapie; 1995; 50(6):563-9. PubMed ID: 8745957 [TBL] [Abstract][Full Text] [Related]
12. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale. Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340 [TBL] [Abstract][Full Text] [Related]
14. Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems. Lapeyre-Mestre M; de Castro AM; Bareille MP; Del Pozo JG; Requejo AA; Arias LM; Montastruc JL; Carvajal A Fundam Clin Pharmacol; 2006 Aug; 20(4):391-5. PubMed ID: 16867024 [TBL] [Abstract][Full Text] [Related]
15. Increasing the detection of hepatotoxic response in clinical practice: a quality commitment. Lucena MI; Andrade RJ Rev Esp Enferm Dig; 2005 Mar; 97(3):145-53. PubMed ID: 15839809 [No Abstract] [Full Text] [Related]
16. This month at the NIH: NIDDK forms hepatotoxicity clinical research network. James SP Gastroenterology; 2003 Oct; 125(4):1008. PubMed ID: 14517779 [No Abstract] [Full Text] [Related]
17. Age-related differences in reporting of drug-associated liver injury: data-mining of WHO Safety Report Database. Hunt CM; Yuen NA; Stirnadel-Farrant HA; Suzuki A Regul Toxicol Pharmacol; 2014 Nov; 70(2):519-26. PubMed ID: 25236535 [TBL] [Abstract][Full Text] [Related]
18. Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system. Raschi E; Poluzzi E; Koci A; Salvo F; Pariente A; Biselli M; Moretti U; Moore N; De Ponti F Br J Clin Pharmacol; 2015 Aug; 80(2):285-93. PubMed ID: 25689417 [TBL] [Abstract][Full Text] [Related]
19. [Ticlopidine and hepatic adverse reactions. Data from the Spanish drug surveillance system]. Carvajal García-Pando A; García Ortega P; Rueda de Castro AM; García del Pozo J Med Clin (Barc); 1999 Apr; 112(14):557-8. PubMed ID: 10363248 [No Abstract] [Full Text] [Related]
20. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions. Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]